Amy L. Cutshall, NP

Amy Cutshall practices at Minuteclinic in Annapolis, Maryland.

Amy Cutshall's NPI, 1578214169, was assigned on January 14, 2022. Amy Cutshall holds Indiana license 71011990A.

Amy Cutshall's primary practice is Minuteclinic, at 2601 Riva Rd, Annapolis, MD 21401 in Anne Arundel County. The practice phone is (866) 389-2727.

Amy Cutshall's primary practice is Minuteclinic in Annapolis, Maryland. The medical group on file is CVS MinuteClinic. Dmand AI also links Amy Cutshall to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Amy Cutshall practices. Vendor and product names are available with a free account.

Family is Amy Cutshall's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Amy Cutshall is licensed in Indiana.

Dmand AI lists acute sinusitis, bronchitis, chronic obstructive pulmonary disease (COPD), cold sores or genital herpes, conjunctivitis, contact dermatitis, ear infection and eyelid inflammation among the conditions Amy Cutshall treats.

CMS data shows 317 Medicare services from Amy Cutshall across 9 procedure codes in 2024, for 197 Medicare patients. Medicare paid $13,173 for them. Every service was in an office.

CMS counts 197 Medicare patients who saw Amy Cutshall in 2024. The largest group is 65 to 74, with 101 patients. 73% of them have high blood pressure, and 72% have high cholesterol. 10% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Amy Cutshall's median patient age at 38, with 69% women.

In 2024, Amy Cutshall wrote 294 Medicare Part D claims for 184 patients. 86% of them were for generic drugs. CMS names the drug for 157 of them, across 6 drugs with 11 or more claims each, at $1,343 in total drug cost.

Amy Cutshall accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Amy Cutshall from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $124.